Nevro IPO Research Information

Nevro IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Nevro, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Nevro	NVRO - NYSE	$15.00-$17.00	$18.00	$23.40	7 million	11/6/2014
Underwriter(s): J.P. Morgan, Morgan Stanley
Co-Manager(s): Leerink Partners, JMP Securities
Industry: Health Care
Filing(s): Filed 2014-10-03 Terms Added 2014-10-27

Nevro Quote & Chart - Click for current quote - NVRO

About Nevro (adapted from Nevro prospectus):
They are a medical device company that has developed and commercialized an innovative neuromodulation platform for the treatment of chronic pain.

This description is adapted from Nevro prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Nevro "NVRO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.